Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?
Targeting oncogenes and their interactive partners is an effective approach to developing novel targeted Tanks/Jerseys therapies for cancer and other chronic diseases.We and others have long suggested the MDM2 oncogene being an excellent target for cancer therapy, based on its p53-dependent and -independent oncogenic activities in a variety of canc